Arbutus Biopharma Corp (ABUS) — Cash Flow Reinvestment Rate

Latest as of March 2022: 2.91x

Arbutus Biopharma Corp (ABUS) has a Cash Flow Reinvestment Rate of 2.91x as of March 2022, reinvesting $60.06 Million (capex $75.00K plus investments $-59.98 Million) from operating cash flow of $20.62 Million. Explore ABUS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.91x
(Capex + Investments) / Operating CF

Total Reinvested

$60.06 Million
Capex + Investments

Operating Cash Flow

$20.62 Million
USD

Capital Expenditures

$75.00K
USD

Arbutus Biopharma Corp Cash Flow Reinvestment Rate (2012–2012)

Historical reinvestment intensity for Arbutus Biopharma Corp across 1 annual periods. Also explore how large is Arbutus Biopharma Corp's balance sheet for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Arbutus Biopharma Corp (2012–2012)

Year-by-year capital reinvestment analysis for Arbutus Biopharma Corp. For live market cap and broader valuation context, see Arbutus Biopharma Corp (ABUS) total market value.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2012 0.00x $14.90K $33.27 Million $14.90K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow